Literature DB >> 17154514

Dirhodium(II,II) complexes: molecular characteristics that affect in vitro activity.

Alfredo M Angeles-Boza1, Helen T Chifotides, J Dafhne Aguirre, Abdellatif Chouai, Patty K-L Fu, Kim R Dunbar, Claudia Turro.   

Abstract

In the series Rh2(O2CR)4 (R=CH3, 1; R=CF3, 2), [Rh2(O2CR)2(phen)2]2+ (R=CH3, 3; R=CF3, 4), and [Rh2(O2CR)2(dppz)2]2+ (R=CH3, 5; R=CF3, 6), 2, 4, and 6 are twice as cytotoxic as 1, 3, and 5, respectively. The substitution reactions of 2 with 9-ethylguanine at various temperatures take place at faster rates than those of 1, and the activation energy Ea(1)=69+/-4 kJ/mol is twice Ea(2)=35+/-2 kJ/mol. The higher cytotoxicities of [Rh2(micro-O2CCH3)2(eta1-O2CCH3)L(MeOH)]+ (L=dppz, 7; L=dppn, 8) relative to [Rh2(micro-O2CCH3)2(bpy)L]2+ (L=dppz, 10; L=dppn, 11) are attributed to the labile equatorial groups in 7 and 8 not present in 10 and 11. The toxicities of complexes 1-8 are not related to their charge or the ease by which they transverse the cellular membrane but to the lability of the ligands on the dirhodium core.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 17154514     DOI: 10.1021/jm060592h

Source DB:  PubMed          Journal:  J Med Chem        ISSN: 0022-2623            Impact factor:   7.446


  8 in total

1.  Hybrid organic-inorganic inhibitors of a PDZ interaction that regulates the endocytic fate of CFTR.

Authors:  Rituparna Kundu; Patrick R Cushing; Brian V Popp; Yu Zhao; Dean R Madden; Zachary T Ball
Journal:  Angew Chem Int Ed Engl       Date:  2012-06-14       Impact factor: 15.336

2.  Photoinduced interactions of two dirhodium complexes with d(GTCGAC)2 probed by 2D NOESY.

Authors:  Alycia M Palmer; Jessica D Knoll; Claudia Turro
Journal:  Dalton Trans       Date:  2015-02-28       Impact factor: 4.390

3.  Aerobic reactions of antitumor active dirhodium(II) tetraacetate Rh2(CH3COO)4 with glutathione.

Authors:  Alejandra Enriquez Garcia; Farideh Jalilehvand
Journal:  J Biol Inorg Chem       Date:  2017-12-06       Impact factor: 3.358

4.  Free Rhodium (II) citrate and rhodium (II) citrate magnetic carriers as potential strategies for breast cancer therapy.

Authors:  Marcella L B Carneiro; Eloiza S Nunes; Raphael C A Peixoto; Ricardo G S Oliveira; Luiza H M Lourenço; Izabel C R da Silva; Andreza R Simioni; Antônio C Tedesco; Aparecido R de Souza; Zulmira G M Lacava; Sônia N Báo
Journal:  J Nanobiotechnology       Date:  2011-03-28       Impact factor: 10.435

5.  Confocal fluorescence microscopy studies of a fluorophore-labeled dirhodium compound: visualizing metal-metal bonded molecules in lung cancer (A549) cells.

Authors:  Bruno Peña; Rola Barhoumi; Robert C Burghardt; Claudia Turro; Kim R Dunbar
Journal:  J Am Chem Soc       Date:  2014-05-22       Impact factor: 15.419

6.  Development of a cyclometalated iridium complex with specific intramolecular hydrogen-bonding that acts as a fluorescent marker for the endoplasmic reticulum and causes photoinduced cell death.

Authors:  Soumik Mandal; Dipak K Poria; Ritabrata Ghosh; Partho Sarothi Ray; Parna Gupta
Journal:  Dalton Trans       Date:  2014-12-14       Impact factor: 4.390

7.  Metallothionein: An Aggressive Scavenger-The Metabolism of Rhodium(II) Tetraacetate (Rh2(CH3CO2)4).

Authors:  Daisy L Wong; Martin J Stillman
Journal:  ACS Omega       Date:  2018-11-30

8.  A metal-based inhibitor of NEDD8-activating enzyme.

Authors:  Hai-Jing Zhong; Hui Yang; Daniel Shiu-Hin Chan; Chung-Hang Leung; Hui-Min Wang; Dik-Lung Ma
Journal:  PLoS One       Date:  2012-11-19       Impact factor: 3.240

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.